Cytokines in recurrent pregnancy loss

Clinica Chimica Acta

Volumn 412, Issue 9-10, 2011, Pages 702-708

  Saini, Vandana ^a   Arora, Sarika ^a   Yadav, Amita ^a   Bhattacharjee, Jayashree ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Cytokines; Recurrent pregnancy loss; Th 1 type immunity; Th 2 type immunity; Th17 cells; Treg cells

Indexed keywords

CYTOKINE; FETAL ANTIGEN;

CELL INTERACTION; CELLULAR IMMUNITY; CYTOKINE RELEASE; FETUS CELL; GENETIC INCOMPATIBILITY; GESTATION PERIOD; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFORMATION RETRIEVAL; LIBRARY; LYMPHOCYTE DIFFERENTIATION; MEDICAL LITERATURE; MEDLINE; MOTHER; NIDATION; NONHUMAN; PREGNANCY DISORDER; PRIORITY JOURNAL; RECURRENT ABORTION; REGULATORY T LYMPHOCYTE; REVIEW; SPONTANEOUS ABORTION; TH0 CELL; TH1 CELL; TH17 CELL; TH2 CELL;

ABORTION, HABITUAL; ANIMALS; CYTOKINES; FEMALE; HORMONES; HUMANS; POLYMORPHISM, GENETIC; PREGNANCY; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 79951775417     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.01.002     Document Type: Review

References (124)

1. Sierra S., Stephenson M. Genetics of recurrent pregnancy loss. Semin Reprod Med 2006, 24:17-24.
2. Quenby S., Vince G., Farquharson R., Aplin J. Recurrent miscarriage: a defect in nature's quality control?. Hum Reprod 2002, 17:1959-1963.
3. Babbage S.J., Arkwright P.D., Vince G.S., et al. Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol 2001, 51:21-27.
4. van Mourik M.S.K., Macklon N.S., Heijnen C.J. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukocyt Biol 2009, 85:4-19.
5. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
6. Erdmann A.A., Jung U., Foley J.E., Toda Y., Fowler D.H. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection. Biol Blood Marrow Transplant 2004, 10:604-613.
7. Burns W.R., Wang Y., Tang P.C.Y., et al. Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries. Am J Transplant 2005, 5:1226-1236.
8. Nickerson P., Steurer W., Steiger J., Zheng X., Steele A.W., Strom T.B. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994, 6:757-764.
9. Strom T.B., Chaudury P.R., Manfro R., et al. The Th1/Th2 paradigm and allograft response. Curr Opin Immunol 1996, 8:688-693.
10. Li X.C., Zand M.S., Li Y., Zheng X.X., Strom T.B. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol 1998, 161:2241-2247.
11. Dealtry G.B., O'Farrell M.K., Fernandez N. The Th2 cytokine environment of the placenta. Int Arc Allergy Immunol 2000, 123:107-119.
12. Piccinni M.P., Beloni L., Livi C., Maggi E., Scarselli G., Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998, 4:1020-1024.
13. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997, 18:478-482.
14. Bates M.D., Quenby S., Takakuwa K., Johnson P.M., Vince G.S. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss?. Hum Reprod 2002, 17:2439-2444.
15. Saito S., Sakai M., Sasaki Y., Tanebe K., Tsuda H., Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999, 117:550-555.
16. Makhseed M., Raghupathy R., Azizieh F., Omu A., Al-Shamali E., Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001, 16:2219-2226.
17. Zhu X.Y., Zhou Y.H., Wang M.Y., Jin L.P., Yuan M.M., Li D.J. Blockade of CD86 signaling facilitates a Th2 bias at the maternal-fetal interface and expands peripheral CD4CCD25C regulatory T cells to rescue abortion-prone fetuses. Biol Reprod 2005, 72:338-345.
18. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol Today 1993, 14:353-356.
19. Chaouat G., Lédée-Bataille N., Zourbas S., et al. Cytokines, implantation and early abortion: re-examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept. Am J Reprod Immunol 2003, 50:177-186.
20. Peck A., Mellins E.D. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2010, 129:147-153.
21. Crome S.Q., Wang A.Y., Levings M.K. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010, 159:109-119.
22. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
23. Akbar A.N., Vukmanovic-Stejic M., Taams L.S., Macallan D.C. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007, 7:231-237.
24. Imura H., Fukata J., Mori T. Cytokines and endocrine function: interaction between the immune and neuroendocrine systems. Clin Endocrinol 1991, 25:107-115.
25. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
26. Walia G.K., Mukhopadhyay R., Saraswathy K.N., Puri M., Chahal S.M.S. Immuno-molecular etiology of recurrent pregnancy loss and the anthropological perspective. Int J Hum Genet 2008, 8:227-235.
27. Lin H., Mosmann T.R., Guilbert L., Tuntipopipat S., Wegmann T.G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993, 151:4562-4573.
28. Prete D., De Carli G., Lammel M., et al. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 1995, 86:250-257.
29. Hill J.A., Polgar K., Anderson D.J. T-helper1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995, 273:1933-1936.
30. Yamada H., Polgar K., Hill J.A. Cell mediated immunity to trophoblast antigens in women with recurrent spontaneous abortions. Am J Obstet Gynecol 1994, 170:1339-1344.
31. Hill J.A. T-helper-1 type immunity to trophoblasts: evidence for a new immunological mechanism for recurrent abortion in women. Hum Reprod 1995, 10:114-120.
32. Chaouat G., Menu E., Clark D., Minkowsky M., Wegmann T.G. Control of fetal survival in CBA×DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990, 89:447-458.
33. Robertson S.A., Seamark R.F., Guilbert L.J., Wegmann T.G. The role of cytokines in gestation. Crit Rev Immunol 1994, 14:239-292.
34. Raghupathy R., Makhseed M., Azizieh F., Hassan N., Al-Azemi M., Al-Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999, 196:122-130.
35. Kwak-Kim J.Y., Chung-Bang H.S., Ng S.C., et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003, 18:767-773.
36. Clark D.A., Chaouat G., Arck P.C., Mittruecker H.W., Levy G.A. Cytokine-dependent abortion in CBA 3 DBA/2 mice is mediated procoagulant fgl2 prothrombinase. J Immunol 1998, 160:545-549.
37. Knackstedt M., Ding J.W., Arck P.C., et al. Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 2001, 46:196-210.
38. Drake B.L., Head J.R. Murine trophoblasts can be killed by lymphokine activated killer cells. J Immunol 1989, 143:9-17.
39. Lédée-Bataille N., Dubanchet S., Coulomb-L'hermine A., Durand-Gasselin I., Frydman R., Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004, 81:59-65.
40. Jasper M.J., Tremellen K.P., Robertson S.A. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 2006, 12:301-308.
41. Nakashima A., Ito M., Shima T., Bac N.D., Hidaka T., Saito S. Accumulation of IL-17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol 2010, 64:4-11.
42. Wang W.J., Hao C.F., et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol 2010, 84:164-170.
43. Arruvito L., Billordo A., Capucchio M., Prada M.E., Fainboim L. IL-6 trans-signaling and the frequency of CD4+FOXP3+ cells in women with reproductive failure. J Reprod Immunol 2009, 82:158-165.
44. Sasaki Y., Sakai M., Miyazaki S., Higuma S., Shiozaki A., Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004, 10:347-353.
45. Yang H., Qiu L., Chen G., Ye Z., Lu C., Lin Q. Proportional change of CD4+CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil Steril 2008, 89:656-661.
46. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
47. Yang Y., Huang C.T., Huang X., Pardoll D.M. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 2004, 5:508-515.
48. Tabibzadeh S. Human endometrium: an active site of cytokine production and action. Endocrinol Rev 1991, 12:272-290.
49. Tabibzadeh S., Sun X.Z. Cytokine expression in human endometrium throughout the menstrual cycle. Hum Reprod 1992, 7:1214-1221.
50. Yui J., Garcia-Lloret M., Wegmann T.G., Guilbert L.J. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994, 15:819-835.
51. Haddad E.K., Duclos A.J., Antecka E., Lapp W.S., Baines M.G. Role of interferon-gamma in the priming of decidual macrophages for nitric oxide production and early pregnancy loss. Cell Immunol 1997, 181:68-75.
52. Knofler M., Mosl B., Bauer S., Griesinger G., Husslein P. TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta 2000, 21:525-535.
53. Jokhi P.P., King A., Boocock C., Loke Y.W. Secretion of colony stimulating factor-1 by human first trimester placental and decidual cell populations and the effect of this cytokine on trophoblast thymidine uptake in vitro. Hum Reprod 1995, 10:2800-2807.
54. Hamilton G.S., Lysiak J.J., Watson A.J., Lala P.K. Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J Endocrinol 1998, 159:69-77.
55. King A. Uterine leukocytes and decidualization. Hum Reprod Update 2000, 6:28-36.
56. Stewart C.L., Kaspar P., Brunet L.J., et al. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 1992, 359:76-79.
57. Tabibzadeh S. Ubiquitous expression of TNF a/cachectin in human endometrium. Am J Reprod Immunol 1991, 26:1-4.
58. Hunt J.S., Chen H.L., Hu X.L., Tabibzadeh S. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Hum Reprod 1992, 47:141-147.
59. Philippeaux M.M., Piguet P.F. Expression of tumour necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 1993, 143:480-486.
60. Haimovici F., Hill J.A., Anderson D.J. The effects of soluble products of activated lymphocytes and macrophages on blastocyts implantation events in vitro. Biol Reprod 1991, 44:69-75.
61. Suffys P., Beyaert R., Van R.F., Fiers W. TNF in combination with interferon-gamma is cytotoxic to normal, untransformed mouse and rat embryo fibroblast-like cells. Anticancer Res 1989, 9:167-171.
62. Müeller-Eckhardt G., Mallmann P., Neppert J., et al. Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortion. German RSA/IVIG study group. J Reprod Immunol 1994, 27:95-109.
63. Jenkins C., Roberts J., Wilson R., MacLean M.A., Shilito J., Walker J.J. Evidence of a TH1 type response associated with recurrent miscarriage. Fertil Steril 2000, 6:1206-1208.
64. Trincheiri G. Interleukin-12 and its role in the generation of Th-1 cells. Immunol Today 1993, 14:335-338.
65. Krishnan L., Guilbert L.J., Wegmann T.G., Belosevic M., Mosmann T.R. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J Immunol 1996, 156:653-662.
66. Daher S., Fonseca F., Ribeiro O.G., Musatti C.C., Gerbase-DeLima M. Tumor necrosis factor during pregnancy and the onset of labor and spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 1999, 83:77-79.
67. Hehlgans T., Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005, 115:1-20.
68. Kwak-Kim J.Y., Gilman-Sachs A., Kim C.E. T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy 2005, 88:64-79.
69. Garcia-Lloret M.I., Winkler-Lowen B., Guilbert L.J. Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-α. A model for hematogenous initiation of placental inflammations. J Leukocyt Biol 2000, 68:903-908.
70. Fortunato S.J., Menon R., Lombardi S.J. Support for an infection induced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol 2001, 184:1392-1398.
71. Raghupathy R., Makhseed M., Azizieh F., Omu A., Gupta M., Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000, 15:713-718.
72. Lim K.J., Odukoya O.A., Ajjan R.A., Li T.C., Weetman A.P., Cooke I.D. Profile of cytokine mRNA expression in peri-implantation human endometrium. Mol Hum Reprod 1998, 4:77-81.
73. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000, 47:87-103.
74. Vives A., Balasch J., Yague J., Quinto L., Ordi J., Vanrell J.A. Type-1 and type-2 cytokines in human decidual tissue and trophoblasts from normal and abnormal pregnancies detected by reverse transcriptase polymerase chain reaction (RT-PCR). Am J Reprod Immunol 1999, 42:361-368.
75. Lea R.G., Tulppala M., Critchley H.O. Deficient syncytiotrophoblast tumour necrosis factor-alpha characterizes failing first trimester pregnancies in a sub-group of recurrent miscarriage patients. Hum Reprod 1997, 12:1313-1320.
76. Quenby S., Bates M., Doig T., et al. Pre-implantation endometrial leucocytes in women with recurrent miscarriages. Hum Reprod 1999, 14:737-741.
77. Lim K.J., Odukoya O.A., Li T.C., Cooke I.D. Cytokines and immuno-endocrine factors in recurrent miscarriage. Hum Reprod Update 1996, 2:469-481.
78. Piccinni M.P., Scaletti C., Vultaggio A., Maggi E., Romagnani S. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J Reprod Immunol 2001, 52:35-43.
79. Piccinni M.P., Giudizi M.G., Biagiotti R., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cells clones. J Immunol 1995, 155:128-133.
80. Miyaura H., Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002, 168:1087-1094.
81. Reshef E., Lei Z.M., Rao C.V., Pridham D.D., Chegini N., Luborsky J.L. The presence of gonadotrophin receptors in non pregnant uterus, human placenta, fetal membranes and decidua. J Clin Endocrinol Metab 1990, 70:421-430.
82. Bonney R.C., Watson H., Beesley J.S., Higham JM, Rogers V, Franks S. Endometrial phospholipases A2, polycystic ovaries and pelvic pain. Br J Obstet Gynaecol 1992, 99:486-491.
83. Kalra P.S., Sahu A., Kalra S.P. Interleukin 1 inhibits the ovarian steroid induced LH surge and release of hypothalamic LH-RH in rats. Endocrinology 1990, 126:2145-2152.
84. Ojeda S.R., Urbanski H.F., Costa M.E., Hill D.F., Moholt-Siebert M. Involvement of transforming growth factor alpha in the release of luteinizing hormone-releasing hormone from the developing female hypothalamus. Proc Natl Acad Sci USA 1990, 87:9698-9702.
85. Marquette C., Ban E., Fillon G., Haour F. Receptors for interleukin 1, 2 and 6 in mouse, rat and human pituitary. Neuroendocrinol 1990, 52:48.
86. Scarborough D.E. Cytokine modulation of pituitary hormone secretion. Ann NY Acad Sci 1990, 594:169-187.
87. Piccinni M.P., Bani D., Beloni L., et al. Relaxin favors the development of activated human T cells into Th1-like effectors. Eur J Immunol 1999, 29:2241-2247.
88. Monk J.M., Leonard S., McBey B.A., Croy B.A. Induction of murine spiral artery modification by recombinant human interferon-gamma. Placenta 2005, 26:835-838.
89. Maret A., Coudert J.D., Garidou L., et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor α expression in hematopoietic cells. Eur J Immunol 2003, 33:512-521.
90. Fox H.S., Bond B.L., Parslow T.G. Estrogen regulates the IFN-γ promoter. J Immunol 1991, 146:4362-4367.
91. Robertson M.J., Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990, 76:2421-2438.
92. Prigoshin N., Tambutti M., Larriba J., Gogorza S., Testa R. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol 2004, 52:36-41.
93. Wilson A.G., di Giovine F.S., Blakemore A.I.F., Duff G.W. Single base polymorphism in the tumour necrosis factor-α (TNF-α) gene detectable by NcoI restriction of the PCR product. Hum Mol Genet 1992, 1:353.
94. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on the transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
95. Turner D.M., Williams D.M., Sankaram D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the IL-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
96. Pravica V., Asderakis A., Peerey C., Hajeer A., Sinnott P.J., Hutchinson I.V. In vitro production of IFN gamma correlates with CA repeat polymorphism in human IFN-gamma gene. Eur J Immunogenet 1999, 26:1-3.
97. Bidwell J., Keen L., Gallagher G., et al. Cytokine gene polymorphism in human disease: online databases. Genes Immunol 2001, 1:3-19.
98. Reid J.G., Simpson N.A., Walker R.G., et al. The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 2001, 45:35-40.
99. Daher S., Shulzhenko N., Morgun A., et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 2003, 58:69-77.
100. Costeas P.A., Koumouli A., Giantsiou-Kyriakou A., Papaloizou A., Koumas L. Th2/Th3 cytokine genotypes are associated with pregnancy loss. Hum Immunol 2004, 65:135-141.
101. Engel S.A., Erichsen H.C., Savitz D.A., Thorp J., Chanock S.J., Olshan A.F. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiol 2005, 16:469-477.
102. Pietrowski D., Bettendorf H., Keck C., et al. Lack of association of TNFa gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol 2004, 61:51-58.
103. Kamali-Sarvestani E., Zolghadri J., Gharesi-Fard B., Sarvari J. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol 2005, 65:171-178.
104. Choi B.C., Polgar K., Xiao L., Hill J.A. Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000, 15:46-59.
105. Somigliana E., Vigano P., Vignali M. Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer function?. Hum Reprod Update 1999, 5:40-51.
106. Kinsky R., Delage G., Rosin N., Thang M.N., Hoffmann M., Chaouat G. A murine model of NK cell mediated resorption. Am J Reprod Immunol 1990, 23:73-77.
107. Paganin C., Matteucci C., Cenzuales S., Mantovani A., Allavena P. IL-4 inhibits binding and cytotoxicity of NK cells to vascular endothelium. Cytokine 1994, 6:135-140.
108. Seo N., Tokura Y., Furukawa F., Takigawa M. Down-regulation of tumoricidal NK and NK T cell activities by MHC Kb molecules expressed on Th2-type - delta T αβ T cells co-infiltrating in early B16 melanoma lesions. J Immunol 1998, 161:4138-4145.
109. Deniz G., Akdis M., Aktas E., Blaser K., Akdis C.A. Human NK1 and NK2 subsets determined by purification of IFN-γ-secreting and IFN-γ-nonsecreting NK cells. Eur J Immunol 2002, 32:879-884.
110. Loza M.J., Peters S.P., Zangrilli J.G., Perussia B. Distinction between IL-13+ and IFN-γ+ natural killer cells and regulation of their pool size by IL-4. Eur J Immunol 2002, 32:413-423.
111. Chaouat G., Meliani A.A., Martal J., et al. IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination and local defect in IL-10 production in this abortion-prone combination is corrected by in vitro injection of IFN-γ. J Immunol 1995, 154:4261-4266.
112. Chaouat G., Menu E., de Smedt D., et al. The emerging role of IL-10 in pregnancy. Am J Reprod Immunol 1996, 35:325-328.
113. Raghupathy R. Th-1 type immunity is incompatible with successful pregnancy. Immunol Today 1997, 10:478-482.
114. Nishino E., Matsuzaki N., Masuhiro K., et al. Trophoblast-derived interleukin-6 (IL-6) regulates human chorionic gonadotropin release through IL-6 receptor on human trophoblasts. J Clin Endocrinol Metab 1990, 71:436-441.
115. Ashkar A.A., Di Santo J.P., Croy B.A. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 1998, 187:217-223.
116. Fallon P.G., Jolin H.E., Smith P., et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002, 17:7-17.
117. Yamamoto H., Fuyama S., Arai S., Sendo F. Inhibition of mouse natural killer cytotoxicity by heparin. Cell Immunol 1985, 96:409-417.
118. Johann S., Zoller C., Haas S., Blumel G., Lipp M., Forster R. Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro. Thromb Haemost 1995, 74:998-1002.
119. Fritchley S.J., Kirby J.A., Ali S. The antagonism of interferon-? (IFN-γ) by heparin: examination of the blockade of class II MHC antigen and heat shock protein-70 expression. Clin Exp Immunol 2000, 120:247-252.
120. Douglas M.S., Rix D.A., Dark J.H., Talbot D., Kirby J.A. Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-γ (IFN-γ). Clin Exp Immunol 1997, 107:578-584.
121. Fornari M.C., Sarto A., Berardi V.E., et al. Effect of ovarian hyper-stimulation on blood lymphocyte subpopulations, cytokines, leptin and nitrite among patients with unexplained infertility. Am J Reprod Immunol 2002, 48:394-403.
122. Marzi M., Vigano A., Trabattoni D., et al. Characterisation of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996, 106:127-133.
123. Tranchot-Diallo J., Gras G., Parnet-Mathieu F., et al. Modulations of cytokine expression in pregnant women. Am J Reprod Immunol 1997, 37:215-216.
124. Leonard S., Murrant C., Tayade C., van den Heuvel M., Watering R., Croy B.A. Mechanisms regulating immune cell contributions to spiral artery modification - facts and hypotheses - a review. Placenta 2006, 27:S40-46.